Oricula Therapeutics
Wa Keeney
About Oricula Therapeutics
Oricula Therapeutics develops and commercializes drugs to prevent hearing loss. The company was incorporated in 2013 and is based in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Grant (Feb 2016)
- Website: oricularx.com
- Phone: 2063227526
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/oricula-therapeutics-145170 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.